Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2015 May;35(5):747-50.
doi: 10.1038/jcbfm.2015.32. Epub 2015 Mar 11.

Striatal blood-brain barrier permeability in Parkinson's disease

Affiliations
Clinical Trial

Striatal blood-brain barrier permeability in Parkinson's disease

Madison T Gray et al. J Cereb Blood Flow Metab. 2015 May.

Abstract

In vivo studies have shown that blood-brain barrier (BBB) dysfunction is involved in the course of Parkinson's disease (PD). However, these have lacked either anatomic definition or the ability to recognize minute changes in BBB integrity. Here, using histologic markers of serum protein, iron, and erythrocyte extravasation, we have shown significantly increased permeability of the BBB in the postcommissural putamen of PD patients. The dense innervation of the striatum by PD-affected regions allows for exploitation of this permeability for therapeutic goals. These results are also discussed in the context of the retrograde trans-synaptic hypothesis of PD spread.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Extravasated erythrocytes and perivascular hemosiderin deposits are more abundant in Parkinson's disease (PD) striatum. (A) Multiple erythrocytes (arrow) lying within the striatal parenchyma adjacent to the wall of a striatal vessel. Scale bar=50 μm. (B) Quantification of extravascular erythrocytes in the striata of control and PD subjects. P<2 × 10−7. Line represents mean. n=11 controls, 12 PD. (C) Representative micrographs of Prussian Blue staining demonstrating perivascular hemosiderin (dark blue) adjacent to ulex europaeus agglutinin-stained vessels (brown) in PD striatum (right) and lack thereof in control tissue (left). Scale bars=50 μm. (D) Quantification of perivascular hemosiderin in the striata of control and PD subjects. P<0.005. Line represents mean. n=11 controls, 12 PD.
Figure 2
Figure 2
Leakage of serum proteins is increased in Parkinson's disease (PD) striatum. (A) Hemoglobin (Hb; green) and ulex europaeus agglutinin-positive vessel (red) staining in control (left) and PD (right) striatum. Scale bars=50 μm. (B) Quantification of the extravascular portion of Hb staining P<2 × 10−5. Line represents mean. n=11 controls, 12 PD. (C) Fibrin(ogen) (green) and UEA-positive vessel (red) staining in control (left) and PD (right) striatum. Scale bars=50 μm. (D) Quantification of the extravascular portion of fibrin(ogen) staining P<3 × 10−5. Line represents mean. n=11 controls, 12 PD.

References

    1. Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM. Hypothesis: a role for EBV-induced molecular mimicry in Parkinson's disease. Parkinsonism Relat Disord. 2014;20:685–694. - PubMed
    1. Freundt EC, Maynard N, Clancy EK, Roy S, Bousset L, Sourigues Y, et al. Neuron-to-neuron transmission of alpha-synuclein fibrils through axonal transport. Ann Neurol. 2012;72:517–524. - PMC - PubMed
    1. Schulz-Schaeffer WJ. The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol. 2010;120:131–143. - PMC - PubMed
    1. Tanji K, Mori F, Mimura J, Itoh K, Kakita A, Takahashi H, et al. Proteinase K-resistant alpha-synuclein is deposited in presynapses in human Lewy body disease and A53T alpha-synuclein transgenic mice. Acta Neuropathol. 2010;120:145–154. - PubMed
    1. Sengillo JD, Winkler EA, Walker CT, Sullivan JS, Johnson M, Zlokovic BV. Deficiency in mural vascular cells coincides with blood-brain barrier disruption in Alzheimer's disease. Brain Pathol. 2012;23:303–310. - PMC - PubMed

Publication types